Home > Insider Trading > Filing (0001415889-22-009867)

Filing Details

Accession Number:: 0001415889-22-009867
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-09-22 16:38:13
Reporting Period:: 2022-09-20

Accepted Time:: 2022-09-22 16:38:13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1070081	Ptc Therapeutics Inc.	PTCT	Pharmaceutical Preparations (2834)	043416587

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1578852	Elliott Mark Boulding	C/O Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080	Exec. Vp And Clo	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-09-20	876	$30.86	61,986	No	4	M	Direct
Common Stock	Disposition	2022-09-20	876	$55.00	61,110	No	4	S	Direct
Common Stock	Acquisiton	2022-09-20	300	$30.86	61,410	No	4	M	Direct
Common Stock	Disposition	2022-09-20	300	$55.00	61,110	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2022-09-20	876	$30.86	70,000	$30.86
Common Stock	Stock Option (Right to Buy)	Disposition	2022-09-20	300	$30.86	69,124	$30.86

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
69,124		2026-01-03	No	4	M	Direct
68,824		2026-01-03	No	4	M	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy)	$51.00	2025-01-01	85,600	85,600	Direct
Common Stock	Stock Option (Right to Buy)	$33.02	2029-01-21	72,500	72,500	Direct
Common Stock	Stock Option (Right to Buy)	$33.02	2029-01-21	17,500	17,500	Direct
Common Stock	Stock Option (Right to Buy)	$51.16	2030-01-28	59,500	59,500	Direct
Common Stock	Stock Option (Right to Buy)	$66.49	2031-01-05	59,500	59,500	Direct
Common Stock	Stock Option (Right to Buy)	$38.10	2032-01-06	54,000	54,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2025-01-01	85,600	85,600	Direct
2029-01-21	72,500	72,500	Direct
2029-01-21	17,500	17,500	Direct
2030-01-28	59,500	59,500	Direct
2031-01-05	59,500	59,500	Direct
2032-01-06	54,000	54,000	Direct

Footnotes

This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 2, 2021.
Currently exercisable.
This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020.
This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023.
This option was granted on January 29, 2020, and vests over four years, with 25% of the shares underlying the option vesting on January 29, 2021, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 29, 2021.
This option was granted on January 6, 2021, and vests over four years, with 25% of the shares underlying the option vesting on January 6, 2022, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 6, 2022.
This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023.